Navigation Links
Watson to Present at the Citi 2012 Global Healthcare Conference
Date:2/16/2012

PARSIPPANY, N.J., Feb. 16, 2012 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today that Paul Bisaro, Watson's President and Chief Executive Officer, will provide an overview and update of the Company's business at the Citi 2012 Global Healthcare Conference on Monday, February 27, 2012 at 11:30 am Eastern Time at The Waldorf Astoria in New York, New York.  The presentation will be webcast live and can be accessed on Watson Pharmaceuticals' Investor Relations Website at http://ir.watson.com.  The webcast can also be accessed at the following URL:

http://www.veracast.com/webcasts/citigroup/healthcare2012/55108485.cfm

An archived version will be available approximately one hour after the live presentation ends and can be accessed at the same locations for 90 days.

About Watson Pharmaceuticals, Inc.Watson Pharmaceuticals, Inc. is an integrated global specialty pharmaceutical company. The Company is engaged in the development, manufacturing, marketing and distribution of generic pharmaceuticals and specialized branded pharmaceutical products focused on Urology and Women's Health. Watson has operations in many of the world's established and growing international markets.

For press release and other company information, visit Watson Pharmaceuticals' Web site at http://www.watson.com.

(Logo: http://photos.prnewswire.com/prnh/20100121/LA41294LOGO )CONTACTS: Investors:  

Patty Eisenhaur

  

(862) 261-8141

  

 

  Media:  

Charlie Mayr

  

(862) 261-8030

  

 


'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Watson Launches Generic Biaxin(R) XL
2. Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder
3. Watson Announces Silodosin NDA Accepted for Filing by FDA for the Treatment of Benign Prostatic Hyperplasia
4. Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder
5. Watson Announces United States Availability of RAPAFLO(TM) (silodosin), a Novel New Treatment in Benign Prostatic Hyperplasia (BPH)
6. Watson and Barr Settle Lawsuit Over Oxytrol(R)
7. Watson to Host Conference Call and Webcast to Discuss Fourth Quarter 2009 Earnings and 2010 Outlook
8. Watson Completes Acquisition of Eden Biodesign
9. Watson to Present at Credit Suisse Healthcare Conference
10. Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy
11. Watson Files FDA Application for Generic Rozerem(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2020)... ... June 23, 2020 , ... ... leading provider of center-based, Applied Behavioral Analysis ("ABA") therapy, today announced the ... in the greater-Indianapolis market. This acquisition will make Lighthouse Autism Center one ...
(Date:6/23/2020)... ... June 23, 2020 , ... Construction at the Kasemrad Hospital ... a greatly enlarged and enhanced medical facility. Penetron crystalline technology was ... rooftop garden. , Part of the Bangkok Chain Hospital (BCH) network of private ...
(Date:6/19/2020)... ... June 19, 2020 , ... Food Equality Initiative (FEI), a nonprofit ... allergies and celiac disease announced the first of the “ For the Health” webinar ... for Friday, June 19, 2020, from 11:00, am EST - 12:00 pm EST. ...
Breaking Medicine Technology:
(Date:6/28/2020)... ... , ... Medisend College of Biomedical Engineering Technology, a Dallas-based ... prepares graduates for professional careers as field service engineers and biomedical equipment technicians, ... Ms. Williams currently serves as Associate Vice Chancellor of Workforce and Community Initiatives ...
(Date:6/28/2020)... MONTREAL (PRWEB) , ... June 27, 2020 , ... The ... cashmere folds of hundreds of rolls of toilet paper. Yet, it was the first ... hoarding seems sensible in theory. The more you have stockpiled, the less need to ...
(Date:6/25/2020)... ... 25, 2020 , ... Denials Management, Inc. has just published The Health Insurance ... appeals for denials of mental health and substance use disorder (MH/SUD) treatment services. It ... rights and explain the steps in the appeals process. Complimentary copies of the ...
(Date:6/24/2020)... Ga. (PRWEB) , ... June 24, 2020 , ... ... and population health management, today announced that Wexford Physician Hospital Organization (PHO) has ... quality and cost goals within the framework of value-based care. Use of Population ...
(Date:6/23/2020)... ... ... Oak Street Health, a network of primary care centers that delivers value-based care ... the company’s first centers in New York and Mississippi anticipated to open later this ... center in Jackson, Miss. , “The planned opening of our first centers in ...
Breaking Medicine News(10 mins):